Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$0.87 -0.01 (-1.59%)
Closing price 07/3/2025 03:26 PM Eastern
Extended Trading
$0.87 0.00 (0.00%)
As of 07/3/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/27/2025
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2025
3:19 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:23 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/02/2025
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/30/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
4:59 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
05/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/15/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
7:31 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
04/29/2025
3:15 PM		Biodexa Pharmaceuticals (Filer)
Form POS AM
04/17/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:41 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM		Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
Top Picks for Trump’s Pro-Crypto America (Ad)

Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…

Claim your pass to the Crypto Community Summit here (free for a limited time)
01/17/2025
3:21 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
Top Picks for Trump’s Pro-Crypto America (Ad)

Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…

Claim your pass to the Crypto Community Summit here (free for a limited time)
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM		Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM		Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored